Evaluation of Skin Viscoelasticity in Type 1 Neurofibromatosis Patients

Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The...

Full description

Saved in:
Bibliographic Details
Published inSkin pharmacology and physiology Vol. 19; no. 1; pp. 22 - 27
Main Authors Mimoun, N., Razzouq, N., Wolkenstein, P., Moreno, J.C., Marty, J.P., Lantieri, L., Astier, A., Paul, M.
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.01.2006
Subjects
Online AccessGet full text
ISSN1660-5527
1660-5535
DOI10.1159/000089140

Cover

Abstract Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch.
AbstractList Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch.
Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch. Copyright © 2006 S. Karger AG, Basel
Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch.Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch.
Author Moreno, J.C.
Marty, J.P.
Razzouq, N.
Paul, M.
Astier, A.
Wolkenstein, P.
Mimoun, N.
Lantieri, L.
Author_xml – sequence: 1
  givenname: N.
  surname: Mimoun
  fullname: Mimoun, N.
– sequence: 2
  givenname: N.
  surname: Razzouq
  fullname: Razzouq, N.
– sequence: 3
  givenname: P.
  surname: Wolkenstein
  fullname: Wolkenstein, P.
– sequence: 4
  givenname: J.C.
  surname: Moreno
  fullname: Moreno, J.C.
– sequence: 5
  givenname: J.P.
  surname: Marty
  fullname: Marty, J.P.
– sequence: 6
  givenname: L.
  surname: Lantieri
  fullname: Lantieri, L.
– sequence: 7
  givenname: A.
  surname: Astier
  fullname: Astier, A.
– sequence: 8
  givenname: M.
  surname: Paul
  fullname: Paul, M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16247246$$D View this record in MEDLINE/PubMed
BookMark eNptkM9LwzAUx4NM3A89eBakeBA81CVZkzRHGXMKooLTa0nbV8nWNjNphf33RjsnDHN54b3P9_H4DFGvNjUgdErwNSFMjrF_sSQRPkADwjkOGZuw3u5PRR8NnVtiTLkg_Aj1CaeRoBEfoPnsU5WtarSpA1MELytdB2_aZQZK5Rqd6WYT-NZis4aABI_QWlPo1JpKNcZpFzz7KNSNO0aHhSodnGzrCL3ezhbTu_DhaX4_vXkIs4iyJkylJIClgIJMVCS5VAApZ0zFnKaM5VkWxaKIVBwLWpAUcqkIZzSmUqSEynwyQpfd3rU1Hy24Jqn8tVCWqgbTukRgIgWLpQcv9sClaW3tb0soZZTLSAoPnW-hNq0gT9ZWV8pukl8_HrjqgMwa5ywUfwhOvt0nO_eeHe-x3t6P2cYqXf6bOOsSK2Xfwe52d9MvyLSMJA
CitedBy_id crossref_primary_10_1016_j_anplas_2011_08_006
crossref_primary_10_1016_j_bjps_2011_11_034
crossref_primary_10_1016_j_neuchi_2010_02_021
crossref_primary_10_1016_j_joms_2012_03_026
crossref_primary_10_1186_s40349_016_0065_8
crossref_primary_10_1097_SCS_0000000000004685
crossref_primary_10_14228_jpr_v1i1_32
crossref_primary_10_1016_j_jcms_2015_06_023
crossref_primary_10_1097_PRS_0000000000002021
crossref_primary_10_1097_PRS_0b013e3181d180e9
crossref_primary_10_1186_s13023_022_02223_x
Cites_doi 10.1016%2F1076-0512%2895%2900057-7
10.1159%2F000246427
10.1046%2Fj.1365-2362.1997.2050752.x
10.1034%2Fj.1600-0846.2000.006004239.x
10.1159%2F000246472
10.1001%2Farchderm.136.10.1207
10.1111%2Fj.1750-3639.1995.tb00589.x
10.1111%2Fj.1525-1470.1996.tb00725.x
10.1046%2Fj.1365-2230.2000.00627.x
10.1046%2Fj.1365-2133.2001.04067.x
10.1046%2Fj.1365-2362.1996.154303.x
10.1111%2Fj.1749-6632.1986.tb48079.x
10.1016%2FS0092-8674%2801%2900245-8
10.1111%2Fj.1365-2230.1994.tb01140.x
10.1002%2Fjnr.1142
10.1080%2F000155500750012135
10.1016%2FS0190-9622%2896%2990601-5
10.1084%2Fjem.194.1.57
10.1080%2F000155599750010724
10.1046%2Fj.1365-4362.1997.00041.x
10.1111%2Fj.1365-2133.1994.tb03377.x
10.1046%2Fj.1523-1747.1999.00609.x
10.1016%2FS1471-4914%2801%2901955-4
10.1016%2FS0001-4001%2899%2980095-6
ContentType Journal Article
Copyright 2006 S. Karger AG, Basel
(c) 2006 S. Karger AG, Basel
Copyright S. Karger AG Dec 2005
Copyright_xml – notice: 2006 S. Karger AG, Basel
– notice: (c) 2006 S. Karger AG, Basel
– notice: Copyright S. Karger AG Dec 2005
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QO
7U7
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
C1K
CCPQU
FR3
FYUFA
GHDGH
K9.
M0S
M1P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1159/000089140
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Toxicology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Toxicology Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

CrossRef
Technology Research Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1660-5535
EndPage 27
ExternalDocumentID 937949711
16247246
10_1159_000089140
89140
Genre Journal Article
GroupedDBID ---
0R~
0~5
0~B
123
1CY
30W
328
3O.
3V.
4.4
53G
7X7
88E
8AO
8FI
8FJ
AAYIC
ABJNI
ABPAZ
ABUWG
ACGFO
ACGFS
ACIWK
ACPRK
ACPSR
ADBBV
AENEX
AEYAO
AFJJK
AFKRA
AFRAH
AHMBA
ALDHI
ALMA_UNASSIGNED_HOLDINGS
AZPMC
BENPR
BPHCQ
BVXVI
CAG
CCPQU
COF
CYUIP
DU5
E0A
EBS
EJD
EMOBN
F5P
FB.
FYUFA
HMCUK
HZ~
IAO
IHR
IY7
KUZGX
M1P
O1H
O9-
P2P
PQQKQ
PROAC
PSQYO
RKO
RXVBD
UJ6
UKHRP
AAYXX
ABBTS
ABWCG
AHFRZ
CITATION
ITC
PHGZM
PHGZT
PJZUB
PPXIY
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7U7
7XB
8FD
8FK
C1K
FR3
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c425t-b991e097ef13a4969aeeb655a862b55dcc487f4a8872f1bed9a16528297b129d3
IEDL.DBID 7X7
ISSN 1660-5527
IngestDate Fri Sep 05 01:46:52 EDT 2025
Sat Aug 23 14:10:29 EDT 2025
Wed Feb 19 01:42:49 EST 2025
Thu Apr 24 23:03:47 EDT 2025
Wed Oct 01 06:30:59 EDT 2025
Thu Aug 29 12:04:13 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Skin viscoelasticity
Neurofibromatosis type 1
Cutometer
Language English
License Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
https://www.karger.com/Services/SiteLicenses
(c) 2006 S. Karger AG, Basel
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c425t-b991e097ef13a4969aeeb655a862b55dcc487f4a8872f1bed9a16528297b129d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 16247246
PQID 225269497
PQPubID 29225
PageCount 6
ParticipantIDs proquest_miscellaneous_70197589
proquest_journals_225269497
pubmed_primary_16247246
crossref_primary_10_1159_000089140
karger_primary_89140
crossref_citationtrail_10_1159_000089140
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-01-01
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – month: 01
  year: 2006
  text: 2006-01-01
  day: 01
PublicationDecade 2000
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Basel
PublicationTitle Skin pharmacology and physiology
PublicationTitleAlternate Skin Pharmacol Physiol
PublicationYear 2006
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References Grudeva-Popova J, Dobrev H: Biomechanical measurement of skin distensibility in scleroderma of Buschke with multiple myeloma. Clin Exp Dermatol 2000;25:247-249.1084450810.1046%2Fj.1365-2230.2000.00627.x
Fong SSL, Hung LK, Cheng JCY: The Cutometer and ultrasonography in the assessment of postburn hypertrophic scar - A preliminary study. Burns 1997;23:S12-S18.
Henry F, Goffin V, Piérard-Franchimont C, Piérard GE: Mechanical properties of skin in Ehlers-Danlos syndrome, types I, II and III. Pediatr Dermatol 1996;13:464-467.898705410.1111%2Fj.1525-1470.1996.tb00725.x
Chanoki M, Ishii M, Fukai K, Kobayashi H, Hamada T, Muragaki Y, Ooshima A: Immunohistochemical localization of type I, III, IV, V, and VI collagens and laminin in neurofibroma and neurofibrosarcoma.Am J Dermopathol 1991;13:365-373.
Lakkis MM, Tennekoon GI: Neurofibromatosis type 1: answers from animal models. J Neurosci Res 2001;65:191-194.1149435310.1002%2Fjnr.1142
Dobrev H: In vivo study of skin mechanical properties in psoriasis vulgaris. Acta Derm Venereol 2000;80:263-266.1102885810.1080%2F000155500750012135
Peltonen J, Penttinnen R, Larjava H, Aho HJ: Collagens in neurofibromas and neurofibroma cell cultures. Ann NY Acad Sci1986;486:260-270.310539110.1111%2Fj.1749-6632.1986.tb48079.x
Zhang LQ, Laato M, Muona P, Kalimo H, Peltonen J: Normal and hypertrophic scars: quantification and localization of messenger RNAs for type I, III and VI collagens. Br J Dermatol 1994;130:453-459.818610910.1111%2Fj.1365-2133.1994.tb03377.x
Giorno R, Lieber J, Claman HM: Ultrastructural evidence for mast cell activation in a case of neurofibromatosis. Neurofibromatosis 1989;2:35-41.2517021
Smirnov AV: Immunomorphologic study of the extracellular matrix in neurofibroma and benign schwannoma. Arkh Patol 1991;53:40-47.1859281
Enomoto DNH, Mekkes JR, Bossuyt PMM, Hoekzema R, Bos JD: Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol 1996;35:381-387.878427310.1016%2FS0190-9622%2896%2990601-5
Pans A: Nouvelles perspectives dans l'étiologie des hernies de l'aine. Chirurgie 1999;124:288-297.1042930310.1016%2FS0001-4001%2899%2980095-6
Martolo O, Henry F, Piérard GE: Seuil liminaire de la perception d'un étirement cutané. Acta Derm Venereol 2001;128:119-122.
Nikkels-Tassoudji N, Henry F, Piérard-Franchimont C, Piérard GE: Computerized evaluation of skin stiffening in scleroderma. Eur J Clin Invest1996;26:457-460.881715810.1046%2Fj.1365-2362.1996.154303.x
Pans A, Piérard GE, Albert A, Desaive C: Adult groin hernias: new insight into their biomechanical characteristics. Eur J Clin Invest 1997;27:863-868.937376710.1046%2Fj.1365-2362.1997.2050752.x
Atit RP, Crowe MJ, Greenhalgh DG, Wenstrup RJ, Ratner N: The NF1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 1999;112:835-842.1038372710.1046%2Fj.1523-1747.1999.00609.x
Ingram DA, Hiatt K, King AJ, et al: Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 2001;194:57-69.1143547210.1084%2Fjem.194.1.57
Cichowski K, Jacks T: NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001;104:593-604.1123941510.1016%2FS0092-8674%2801%2900245-8
Karnovel SL, Kallioinen M, Ylä-Outinen H, Pöyjönen M, Oikarinen A, Peltonen J: Occult neurofibroma and increased S 100 protein in the skin of patients with neurofibromatosis type 1: new insight to the etiopathomechanism of neurofibromas. Arch Dermatol 2000;136:1207-1209.1103076610.1001%2Farchderm.136.10.1207
Konomi H, Arima M, Tanaka H, Hayashi T, Ikeda S: Increased deposition of types III and V collagen in neurofibroma tissue from patients with von Recklinghausen disease. Brain Dev 1989;11:378-383.2515769
Piérard GE, Nikkels-Tassoudjin N, Piérard-Franchimont C: Influence of the test area on the mechanical properties of skin. Dermatology 1995;191:9-15.858949910.1159%2F000246472
Henry F, Piérard-Franchimont C, Pans A, Piérard GE: Striae distensae of pregnancy. An in vivo biomechanical evaluation. Int J Dermatol 1997;36:506-508.926874710.1046%2Fj.1365-4362.1997.00041.x
Piérard-Franchimont C, Henry F, Crielaard JM, Piérard GE: Mechanical properties of skin in recombinant human growth factor abusers among adult bodybuilders. Dermatology 1996;192:389-392.886438810.1159%2F000246427
Reed N, Gutmann DH: Tumorigenesis in neurofibromatosis: new insights and potential therapies. Trends Mol Med 2001;7:157-162.1128693910.1016%2FS1471-4914%2801%2901955-4
Dobrev H: Use of Cutometer to assess epidermal hydratation. Skin Res Technol 2000;6:239-244.1142896310.1034%2Fj.1600-0846.2000.006004239.x
National Institutes of Health Consensus Development Conference: Neurofibromatosis. Conference statement. Arch Neurol 1988;45:575-578.3128965
Henry F, Van Look R, Goffin V, Fissette J, Piérard GE: Mechanical properties of skin and liposuction. Dermatol Surg 1996;22:566-568.864647310.1016%2F1076-0512%2895%2900057-7
Deleixhe-Mauhin F, Piérard-Franchimont C, Rorive G, Piérard GE: Influence of chronic haemodialysis on the mechanical properties of the skin. Clin Exp Dermatol 1994;19:130-133.805014110.1111%2Fj.1365-2230.1994.tb01140.x
Von Deimling A, Krone W, Menon AG: Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 1995;5:153-162.767065610.1111%2Fj.1750-3639.1995.tb00589.x
Pagnoni A, Kligman AM, Sadiq I, Stoudeyer T: Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm Venereol1999;79:305-310.1042999010.1080%2F000155599750010724
Tsukahara K, Takema Y, Moriwaki S, Fujimura T, Imayama S, Imokawa G: Carbon dioxide laser treatment promotes repair of the three-dimensional network of elastic fibres in rat skin. Br J Dermatol 2001;144:452-458.1125999810.1046%2Fj.1365-2133.2001.04067.x
ref13
ref24
ref12
ref23
ref15
ref14
ref20
ref11
ref22
ref10
ref21
ref2
ref1
ref17
ref16
ref19
ref18
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – reference: Zhang LQ, Laato M, Muona P, Kalimo H, Peltonen J: Normal and hypertrophic scars: quantification and localization of messenger RNAs for type I, III and VI collagens. Br J Dermatol 1994;130:453-459.818610910.1111%2Fj.1365-2133.1994.tb03377.x
– reference: Konomi H, Arima M, Tanaka H, Hayashi T, Ikeda S: Increased deposition of types III and V collagen in neurofibroma tissue from patients with von Recklinghausen disease. Brain Dev 1989;11:378-383.2515769
– reference: Grudeva-Popova J, Dobrev H: Biomechanical measurement of skin distensibility in scleroderma of Buschke with multiple myeloma. Clin Exp Dermatol 2000;25:247-249.1084450810.1046%2Fj.1365-2230.2000.00627.x
– reference: Enomoto DNH, Mekkes JR, Bossuyt PMM, Hoekzema R, Bos JD: Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol 1996;35:381-387.878427310.1016%2FS0190-9622%2896%2990601-5
– reference: Ingram DA, Hiatt K, King AJ, et al: Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 2001;194:57-69.1143547210.1084%2Fjem.194.1.57
– reference: Von Deimling A, Krone W, Menon AG: Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 1995;5:153-162.767065610.1111%2Fj.1750-3639.1995.tb00589.x
– reference: Dobrev H: In vivo study of skin mechanical properties in psoriasis vulgaris. Acta Derm Venereol 2000;80:263-266.1102885810.1080%2F000155500750012135
– reference: Pans A: Nouvelles perspectives dans l'étiologie des hernies de l'aine. Chirurgie 1999;124:288-297.1042930310.1016%2FS0001-4001%2899%2980095-6
– reference: National Institutes of Health Consensus Development Conference: Neurofibromatosis. Conference statement. Arch Neurol 1988;45:575-578.3128965
– reference: Chanoki M, Ishii M, Fukai K, Kobayashi H, Hamada T, Muragaki Y, Ooshima A: Immunohistochemical localization of type I, III, IV, V, and VI collagens and laminin in neurofibroma and neurofibrosarcoma.Am J Dermopathol 1991;13:365-373.
– reference: Smirnov AV: Immunomorphologic study of the extracellular matrix in neurofibroma and benign schwannoma. Arkh Patol 1991;53:40-47.1859281
– reference: Reed N, Gutmann DH: Tumorigenesis in neurofibromatosis: new insights and potential therapies. Trends Mol Med 2001;7:157-162.1128693910.1016%2FS1471-4914%2801%2901955-4
– reference: Deleixhe-Mauhin F, Piérard-Franchimont C, Rorive G, Piérard GE: Influence of chronic haemodialysis on the mechanical properties of the skin. Clin Exp Dermatol 1994;19:130-133.805014110.1111%2Fj.1365-2230.1994.tb01140.x
– reference: Karnovel SL, Kallioinen M, Ylä-Outinen H, Pöyjönen M, Oikarinen A, Peltonen J: Occult neurofibroma and increased S 100 protein in the skin of patients with neurofibromatosis type 1: new insight to the etiopathomechanism of neurofibromas. Arch Dermatol 2000;136:1207-1209.1103076610.1001%2Farchderm.136.10.1207
– reference: Henry F, Piérard-Franchimont C, Pans A, Piérard GE: Striae distensae of pregnancy. An in vivo biomechanical evaluation. Int J Dermatol 1997;36:506-508.926874710.1046%2Fj.1365-4362.1997.00041.x
– reference: Nikkels-Tassoudji N, Henry F, Piérard-Franchimont C, Piérard GE: Computerized evaluation of skin stiffening in scleroderma. Eur J Clin Invest1996;26:457-460.881715810.1046%2Fj.1365-2362.1996.154303.x
– reference: Henry F, Van Look R, Goffin V, Fissette J, Piérard GE: Mechanical properties of skin and liposuction. Dermatol Surg 1996;22:566-568.864647310.1016%2F1076-0512%2895%2900057-7
– reference: Lakkis MM, Tennekoon GI: Neurofibromatosis type 1: answers from animal models. J Neurosci Res 2001;65:191-194.1149435310.1002%2Fjnr.1142
– reference: Henry F, Goffin V, Piérard-Franchimont C, Piérard GE: Mechanical properties of skin in Ehlers-Danlos syndrome, types I, II and III. Pediatr Dermatol 1996;13:464-467.898705410.1111%2Fj.1525-1470.1996.tb00725.x
– reference: Fong SSL, Hung LK, Cheng JCY: The Cutometer and ultrasonography in the assessment of postburn hypertrophic scar - A preliminary study. Burns 1997;23:S12-S18.
– reference: Martolo O, Henry F, Piérard GE: Seuil liminaire de la perception d'un étirement cutané. Acta Derm Venereol 2001;128:119-122.
– reference: Giorno R, Lieber J, Claman HM: Ultrastructural evidence for mast cell activation in a case of neurofibromatosis. Neurofibromatosis 1989;2:35-41.2517021
– reference: Pans A, Piérard GE, Albert A, Desaive C: Adult groin hernias: new insight into their biomechanical characteristics. Eur J Clin Invest 1997;27:863-868.937376710.1046%2Fj.1365-2362.1997.2050752.x
– reference: Pagnoni A, Kligman AM, Sadiq I, Stoudeyer T: Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm Venereol1999;79:305-310.1042999010.1080%2F000155599750010724
– reference: Peltonen J, Penttinnen R, Larjava H, Aho HJ: Collagens in neurofibromas and neurofibroma cell cultures. Ann NY Acad Sci1986;486:260-270.310539110.1111%2Fj.1749-6632.1986.tb48079.x
– reference: Piérard GE, Nikkels-Tassoudjin N, Piérard-Franchimont C: Influence of the test area on the mechanical properties of skin. Dermatology 1995;191:9-15.858949910.1159%2F000246472
– reference: Piérard-Franchimont C, Henry F, Crielaard JM, Piérard GE: Mechanical properties of skin in recombinant human growth factor abusers among adult bodybuilders. Dermatology 1996;192:389-392.886438810.1159%2F000246427
– reference: Tsukahara K, Takema Y, Moriwaki S, Fujimura T, Imayama S, Imokawa G: Carbon dioxide laser treatment promotes repair of the three-dimensional network of elastic fibres in rat skin. Br J Dermatol 2001;144:452-458.1125999810.1046%2Fj.1365-2133.2001.04067.x
– reference: Cichowski K, Jacks T: NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001;104:593-604.1123941510.1016%2FS0092-8674%2801%2900245-8
– reference: Atit RP, Crowe MJ, Greenhalgh DG, Wenstrup RJ, Ratner N: The NF1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 1999;112:835-842.1038372710.1046%2Fj.1523-1747.1999.00609.x
– reference: Dobrev H: Use of Cutometer to assess epidermal hydratation. Skin Res Technol 2000;6:239-244.1142896310.1034%2Fj.1600-0846.2000.006004239.x
– ident: ref18
  doi: 10.1016%2F1076-0512%2895%2900057-7
– ident: ref16
  doi: 10.1159%2F000246427
– ident: ref7
  doi: 10.1046%2Fj.1365-2362.1997.2050752.x
– ident: ref17
  doi: 10.1034%2Fj.1600-0846.2000.006004239.x
– ident: ref5
  doi: 10.1159%2F000246472
– ident: ref6
  doi: 10.1001%2Farchderm.136.10.1207
– ident: ref3
  doi: 10.1111%2Fj.1750-3639.1995.tb00589.x
– ident: ref9
  doi: 10.1111%2Fj.1525-1470.1996.tb00725.x
– ident: ref14
  doi: 10.1046%2Fj.1365-2230.2000.00627.x
– ident: ref19
  doi: 10.1046%2Fj.1365-2133.2001.04067.x
– ident: ref12
  doi: 10.1046%2Fj.1365-2362.1996.154303.x
– ident: ref21
  doi: 10.1111%2Fj.1749-6632.1986.tb48079.x
– ident: ref2
  doi: 10.1016%2FS0092-8674%2801%2900245-8
– ident: ref15
  doi: 10.1111%2Fj.1365-2230.1994.tb01140.x
– ident: ref24
  doi: 10.1002%2Fjnr.1142
– ident: ref10
  doi: 10.1080%2F000155500750012135
– ident: ref4
  doi: 10.1016%2FS0190-9622%2896%2990601-5
– ident: ref22
  doi: 10.1084%2Fjem.194.1.57
– ident: ref11
  doi: 10.1080%2F000155599750010724
– ident: ref13
  doi: 10.1046%2Fj.1365-4362.1997.00041.x
– ident: ref20
  doi: 10.1111%2Fj.1365-2133.1994.tb03377.x
– ident: ref23
  doi: 10.1046%2Fj.1523-1747.1999.00609.x
– ident: ref1
  doi: 10.1016%2FS1471-4914%2801%2901955-4
– ident: ref8
  doi: 10.1016%2FS0001-4001%2899%2980095-6
SSID ssj0026716
Score 1.775993
Snippet Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an...
SourceID proquest
pubmed
crossref
karger
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 22
SubjectTerms Adolescent
Adult
Elasticity
Female
Humans
Male
Middle Aged
Neurofibromatosis 1 - physiopathology
Original Paper
Rheology
Skin - physiopathology
Skin Neoplasms - physiopathology
Title Evaluation of Skin Viscoelasticity in Type 1 Neurofibromatosis Patients
URI https://karger.com/doi/10.1159/000089140
https://www.ncbi.nlm.nih.gov/pubmed/16247246
https://www.proquest.com/docview/225269497
https://www.proquest.com/docview/70197589
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1660-5535
  dateEnd: 20231001
  omitProxy: true
  ssIdentifier: ssj0026716
  issn: 1660-5527
  databaseCode: 7X7
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1660-5535
  dateEnd: 20231001
  omitProxy: true
  ssIdentifier: ssj0026716
  issn: 1660-5527
  databaseCode: BENPR
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB7UFfEivl0faxAPXop9JGlzEpVdF0ERUdlbyasgylbtevDfO2mzXQ_qpYc0pDAzyXyTmX4DcGzCWGaF5kGcxiagksaBMtQVO4Q4qpgVuq62uOXDR3o9YiNfm1P5ssrpmVgf1KbU7o78FO3O_XQp0rO398A1jXLJVd9BYx46ESIVZ9TpaBZv8bTufBpxHgaOaMwTC6EDrzkbMxG5K48f7mjxxVVff_wNNmunM1iFFY8WyXmj3jWYs-N1WLrx-fANuOq3ZN2kLIjrpEWenitdWgTFrl568kVwyAWbJCINEQfGxyXC1LJ6rshdw6pabcLjoP9wOQx8a4RA4yabBAphnQ1FaosokVRwIa1VnDGJAYpizGiNgUhBJR4hcREpa4SMOHNZ01ShhzfJFiyMy7HdAWIyjRhQSZtklLICl0mEEWFiMxZrfHbhZCqhXHvecNe-4jWv4wcm8laYXThqp741ZBm_TdpoxNxO8cN7U6HnfhtVeav0Lhy2b9H-XVJDjm35WeWOTh5jHtGF7UZTsy_zmKYx5bv_rrwHy7NblX1YmHx82gPEGRPVq62pB52L_u3d_TdEm9BZ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9VAFD5BNMKGqAheQJkYTdw0tNOZaWdhCFHwIo-4AHN3ZV5NiOYW6SWEH8V_9Jy-rgt1x6aL6WSanPmm8505Z74D8M7H3OSlUxHPuI-EETyyXlCyQ4ytVgbtmmyLUzU-F18ncrIA9_1dGEqr7P-JzY_aV47OyHcQd3TpUme7V78iKhpFwdW-gkaLiqNwd4seW_3x8DNO73vOD_bPPo2jrqhA5BCes8giIQqxzkKZpEZopU0IVklpkNpbKb1zSOFLYXDx8TKxwWuTKEnxxszi3uhTHPcRPBZpLEiqP5vM_TuVNZVWE6XiiITNOiEjJAyNRmSuEzpi-WP7e_KDsr2v_01um03u4BmsdOyU7bVweg4LYfoCnp508fdV-LI_iIOzqmRUuYt9v6xdFZCEU3727I5hEzm3LGGt8Af64xXS4qq-rNm3VsW1fgnnD2K1NVicVtPwCpjPHXJOa0KaCyFLHCbVXsdpyCV3-BzBh95Chet0yqlcxs-i8VekLgZjjuDt0PWqFef4W6fV1sxDl655szd60S3buhhANoLt4S2uNwqimGmobuqC5OvRx9IjWG9nav5lxUXGhdr478jbsDQ-Ozkujg9PjzZheX6iswWLs-ub8Bo5zsy-aZDF4OKhofwbhz8LUg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+skin+viscoelasticity+in+type+1+neurofibromatosis+patients&rft.jtitle=Skin+pharmacology+and+physiology&rft.au=Mimoun%2C+N&rft.au=Razzouq%2C+N&rft.au=Wolkenstein%2C+P&rft.au=Moreno%2C+J+C&rft.date=2006-01-01&rft.issn=1660-5527&rft.volume=19&rft.issue=1&rft.spage=22&rft_id=info:doi/10.1159%2F000089140&rft_id=info%3Apmid%2F16247246&rft.externalDocID=16247246
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1660-5527&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1660-5527&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1660-5527&client=summon